Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)
Hong Kong · Delayed Price · Currency is HKD 25.78
+0.76 (3.04%)
Sep 30, 2025, 4:08 PM HKT
Shanghai Fosun Pharmaceutical (Group) Employees
Shanghai Fosun Pharmaceutical (Group) had 40,557 employees as of December 31, 2024. The number of employees increased by 187 or 0.46% compared to the previous year.
Employees
40,557
Change (1Y)
187
Growth (1Y)
0.46%
Revenue / Employee
1.09M HKD
Profits / Employee
88.43K HKD
Market Cap
82.39B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40,557 | 187 | 0.46% |
| Dec 31, 2023 | 40,370 | 1,971 | 5.13% |
| Dec 31, 2022 | 38,399 | 2,120 | 5.84% |
| Dec 31, 2021 | 36,279 | 4,021 | 12.47% |
| Dec 31, 2020 | 32,258 | 888 | 2.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| JD Health International | 3,564 |
| Innovent Biologics | 5,659 |
| WuXi Biologics | 12,575 |
| Sino Biopharmaceutical | 24,379 |
| Akeso | 3,035 |
| Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
Shanghai Fosun Pharmaceutical (Group) News
- 14 days ago - Fosun’s Henlius in talks with Johnson & Johnson, Roche on cancer drug - South China Morning Post
- 6 months ago - Shanghai Fosun Pharmaceutical reports FY results - Seeking Alpha
- 2 years ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
- 3 years ago - Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech - Forbes
- 3 years ago - Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal - Seeking Alpha
- 4 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 4 years ago - Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse - Seeking Alpha
- 4 years ago - Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million Deal - Seeking Alpha